title: Iron storage proteins are essential for the survival and pathogenesis of Mycobacterium tuberculosis in THP-1 macrophages and the guinea pig model of infection.
abstract: Iron is one of the crucial elements required for the growth of Mycobacterium tuberculosis. However, excess free iron becomes toxic for the cells because it catalyzes the production of reactive oxygen radicals, leading to oxidative damage. Hence, it is essential for the pathogen to have the ability to store intracellular iron in an iron-rich environment and utilize it under iron depletion. M. tuberculosis has two iron storage proteins, namely BfrA (Rv1876; a bacterioferritin) and BfrB (Rv3841; a ferritin-like protein). However, the demonstration of biological significance requires the disruption of relevant genes and the evaluation of the resulting mutant for its ability to survive in the host and cause disease. In this study, we have disrupted bfrA and bfrB of M. tuberculosis and demonstrated that these genes are crucial for the storage and supply of iron for the growth of bacteria and to withstand oxidative stress in vitro. In addition, the bfrA bfrB double mutant (H37Rv ΔbfrA ΔbfrB) exhibited a marked reduction in its ability to survive inside human macrophages. Guinea pigs infected with H37Rv ΔbfrA ΔbfrB exhibited a marked diminution in the dissemination of the bacilli to spleen compared to that of the parental strain. Moreover, guinea pigs infected with H37Rv ΔbfrA ΔbfrB exhibited significantly reduced pathological damage in spleen and lungs compared to that of animals infected with the parental strain. Our study clearly demonstrates the importance of these iron storage proteins in the survival and pathogenesis of M. tuberculosis in the host and establishes them as attractive targets for the development of new inhibitors against mycobacterial infections.
authors.affiliation: Department of Biochemistry, University of Delhi South Campus, New Delhi, India.
authors.forename: P Vineel
authors.initials: PV
authors.lastname: Reddy
authors.forename: Rupangi Verma
authors.initials: RV
authors.lastname: Puri
authors.forename: Aparna
authors.initials: A
authors.lastname: Khera
authors.forename: Anil K
authors.initials: AK
authors.lastname: Tyagi
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D004195:Disease Models, Animal; D005260:Female; D005293:Ferritins / Q000235:genetics / Q000378:metabolism*; D006168:Guinea Pigs; D006801:Humans; D007501:Iron / Q000378:metabolism; D008264:Macrophages / Q000382:microbiology*; D050296:Microbial Viability; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000254:growth & development / Q000378:metabolism* / Q000472:pathogenicity*; D014376:Tuberculosis / Q000382:microbiology*; D014774:Virulence
chemical_list: D001426:Bacterial Proteins; D005293:Ferritins; D007501:Iron
references.citation: Microbiology (Reading). 2002 Oct;148(Pt 10):3007-3017
references.pmid: 12368434
references.citation: PLoS One. 2010 Feb 26;5(2):e9448
references.pmid: 20195478
references.citation: Mol Microbiol. 2003 Mar;47(6):1485-94
references.pmid: 12622807
references.citation: J Bacteriol. 1999 Aug;181(15):4443-51
references.pmid: 10419938
references.citation: J Microbiol. 2010 Oct;48(5):668-73
references.pmid: 21046346
references.citation: J Infect Dis. 1993 Apr;167(4):857-64
references.pmid: 8450251
references.citation: Mol Microbiol. 2003 May;48(3):833-43
references.pmid: 12694625
references.citation: Nat Methods. 2007 Feb;4(2):147-52
references.pmid: 17179933
references.citation: J Bacteriol. 2002 Jul;184(13):3485-91
references.pmid: 12057942
references.citation: J Bacteriol. 1993 Aug;175(16):5186-92
references.pmid: 8349558
references.citation: Mol Microbiol. 1996 Jun;20(6):1127-34
references.pmid: 8809765
references.citation: Infect Immun. 2002 Jul;70(7):3371-81
references.pmid: 12065475
references.citation: J Bacteriol. 1999 Jun;181(12):3730-42
references.pmid: 10368148
references.citation: J Clin Invest. 1993 Mar;91(3):969-76
references.pmid: 8450071
references.citation: J Clin Virol. 2001 Feb;20(3):123-6
references.pmid: 11166659
references.citation: PLoS One. 2008;3(12):e3869
references.pmid: 19052643
references.citation: Mol Microbiol. 2001 Nov;42(3):851-65
references.pmid: 11722747
references.citation: Infect Immun. 2002 Jul;70(7):3923-9
references.pmid: 12065536
references.citation: J Bacteriol. 1999 Mar;181(5):1415-28
references.pmid: 10049371
references.citation: PLoS One. 2011 Apr 08;6(4):e18570
references.pmid: 21494619
references.citation: Tuberculosis (Edinb). 2004;84(3-4):218-27
references.pmid: 15207491
references.citation: J Infect Dis. 2007 Jun 15;195(12):1745-53
references.pmid: 17492589
references.citation: Nature. 1998 Jun 11;393(6685):537-44
references.pmid: 9634230
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7534-9
references.pmid: 11416222
references.citation: PLoS One. 2009 Nov 25;4(11):e8028
references.pmid: 19946376
references.citation: Trends Mol Med. 2001 Mar;7(3):135-7
references.pmid: 11286786
references.citation: Adv Microb Physiol. 1998;40:281-351
references.pmid: 9889981
references.citation: EMBO J. 2003 May 1;22(9):1959-68
references.pmid: 12727864
references.citation: Mol Microbiol. 2007 Mar;63(5):1495-507
references.pmid: 17302823
references.citation: J Immunol. 1999 Jun 1;162(11):6734-9
references.pmid: 10352292